充填仕上げ製造市場は、製薬およびバイオテクノロジー業界での重要な役割と、注射剤および生物学的製剤の必要性によって、予測期間中に1,111億ドルに達すると予測されます。フィルフィニッシュ製造の成長を促す要因には、慢性疾患の増加、人口の高齢化、新しい治療法の開発があります。さらに、無菌処理、自動化システム、および先端材料の技術革新によって、充填仕上げ製造プロセスの効率と費用対効果が向上しました。さらに、充填仕上げ製造サービスを受託製造機関に委託する傾向の高まりが、市場に新たな成長の可能性をもたらしています。これらの製造機関は、専門知識とコストメリットを提供することで、定評のある新興の製薬会社を引き付けています。
目次
Table of Content
1. Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Fill Finish Manufacturing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2. Fill Finish Manufacturing Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Fill Finish Manufacturing Market - Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. Fill Finish Manufacturing Market
10.1. Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. Fill Finish Manufacturing Market Size & Forecast 2024A-2034F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product
11.3.1.1. Consumables
11.3.1.1.1. By Value (USD Million) 2024-2034F
11.3.1.1.2. Market Share (%) 2024-2034F
11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.2. Instruments
11.3.1.2.1. By Value (USD Million) 2024-2034F
11.3.1.2.2. Market Share (%) 2024-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.3. Automated Machines
11.3.1.3.1. By Value (USD Million) 2024-2034F
11.3.1.3.2. Market Share (%) 2024-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Modality
11.3.2.1. Recombinant Proteins
11.3.2.1.1. By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Monoclonal Antibodies
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2. Market Share (%) 2024-2034F
11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Vaccines
11.3.2.3.1. By Value (USD Million) 2024-2034F
11.3.2.3.2. Market Share (%) 2024-2034F
11.3.2.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.4. Cell Therapies and Biological Therapies
11.3.2.4.1. By Value (USD Million) 2024-2034F
11.3.2.4.2. Market Share (%) 2024-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.5. Gene Therapies
11.3.2.5.1. By Value (USD Million) 2024-2034F
11.3.2.5.2. Market Share (%) 2024-2034F
11.3.2.5.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.6. Others
11.3.2.6.1. By Value (USD Million) 2024-2034F
11.3.2.6.2. Market Share (%) 2024-2034F
11.3.2.6.3. Y-o-Y Growth (%) 2024-2034F
11.3.3. By End User
11.3.3.1. Contract Manufacturing Organizations
11.3.3.1.1. By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Biopharmaceutical Companies
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2. Market Share (%) 2024-2034F
11.3.3.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Others
11.3.3.3.1. By Value (USD Million) 2024-2034F
11.3.3.3.2. Market Share (%) 2024-2034F
11.3.3.3.3. Y-o-Y Growth (%) 2024-2034F
12. North America Fill Finish Manufacturing Market Size & Forecast 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2. By Modality
12.3.3. By End User
12.4. Country
12.4.1. United States
12.4.2. Canada
13. Europe Fill Finish Manufacturing Market Size & Forecast 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2. By Modality
13.3.3. By End User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Fill Finish Manufacturing Market Size & Forecast 2024A-2034F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2. By Modality
14.3.3. By End User
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Fill Finish Manufacturing Market Size & Forecast 2024A-2034F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2. By Modality
15.3.3. By End User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Fill Finish Manufacturing Market Size & Forecast 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2. By Modality
16.3.3. By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. Catalent Pharma Solutions
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Baxter BioPharma Solutions
18.3. Lonza
18.4. Recipharm
18.5. Vetter Pharma
18.6. Patheon
18.7. Siegfried
18.8. Nipro Pharma Corporation
18.9. Boehringer Ingelheim
18.10. Jubilant HollisterStier
18.11. Emergent BioSolutions
18.12. Symbiosis Pharmaceutical Services
18.13. Pyramid Laboratories
18.14. Althea Technologies
18.15. Alcami Corporation
18.16. Other Prominent Players
19. Appendix
20. Consultant Recommendation